TY - JOUR
T1 - Clinical features and treatment outcome of desmoid-type fibromatosis
T2 - based on a bone and soft tissue tumor registry in Japan
AU - Nishida, Yoshihiro
AU - Kawai, Akira
AU - Toguchida, Junya
AU - Ogose, Akira
AU - Ae, Keisuke
AU - Kunisada, Toshiyuki
AU - Matsumoto, Yoshihiro
AU - Matsunobu, Tomoya
AU - Takahashi, Kunihiko
AU - Nishida, Kazuki
AU - Ozaki, Toshifumi
N1 - Funding Information:
This work was supported in part by the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid 17H01585 for Scientific Research (A)], and the National Cancer Center Research and Development Fund (29-A-3). We thank the hospitals and medical staff involved in the bone and soft tissue tumor registry. We also thank Ms Nakano and Ishihama for their support of the registry.
Funding Information:
This work was supported in part by the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid 17H01585 for Scientific Research (A)], and the National Cancer Center Research and Development Fund (29-A-3). We thank the hospitals and medical staff involved in the bone and soft tissue tumor registry. We also thank Ms Nakano and Ishihama for their support of the registry.
Publisher Copyright:
© 2019, Japan Society of Clinical Oncology.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Background: Treatment modality of desmoid-type fibromatosis (DF) has changed from surgery with a wide surgical margin to conservative treatment. In this study, tumor characteristics of DF, transition of the treatment modality, and clinical outcome of surgical treatment were analyzed based on data obtained from the bone and soft tissue tumor registry established in Japan. Methods: Data were collected as registration data and follow-up data. Five hundred and thirty registered cases of DF were identified, including 223 cases with follow-up data with or without surgical treatment. Results: The number of registered patients increased gradually. The frequency of surgical treatment was gradually reduced year by year. The 3-year local recurrence free survival (LRFS) was 77.7%, with tumor location and size tending to correlate with LRFS. Interestingly, there was no significant difference in LRFS between wide and marginal margin (P = 0.34). Conclusions: The treatment modality has shifted from surgical to conservative treatment, with risk factors for surgical treatment similar to those noted in previous studies. The National registry system is crucial for a rare disease such as DF, and in the future, a population based registry system should be established to better comprehend the actual status of DF.
AB - Background: Treatment modality of desmoid-type fibromatosis (DF) has changed from surgery with a wide surgical margin to conservative treatment. In this study, tumor characteristics of DF, transition of the treatment modality, and clinical outcome of surgical treatment were analyzed based on data obtained from the bone and soft tissue tumor registry established in Japan. Methods: Data were collected as registration data and follow-up data. Five hundred and thirty registered cases of DF were identified, including 223 cases with follow-up data with or without surgical treatment. Results: The number of registered patients increased gradually. The frequency of surgical treatment was gradually reduced year by year. The 3-year local recurrence free survival (LRFS) was 77.7%, with tumor location and size tending to correlate with LRFS. Interestingly, there was no significant difference in LRFS between wide and marginal margin (P = 0.34). Conclusions: The treatment modality has shifted from surgical to conservative treatment, with risk factors for surgical treatment similar to those noted in previous studies. The National registry system is crucial for a rare disease such as DF, and in the future, a population based registry system should be established to better comprehend the actual status of DF.
KW - Desmoid-type fibromatosis
KW - Marginal resection
KW - Registry
KW - Treatment modality
UR - http://www.scopus.com/inward/record.url?scp=85069471460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069471460&partnerID=8YFLogxK
U2 - 10.1007/s10147-019-01512-z
DO - 10.1007/s10147-019-01512-z
M3 - Article
C2 - 31332613
AN - SCOPUS:85069471460
SN - 1341-9625
VL - 24
SP - 1498
EP - 1505
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 11
ER -